GlassScriptPhysician profile
Jacqueline E Ooten
NPI 1164922811
$3,785.86
in general payments reported to CMS, 2019-2025
23 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $636 · 2022: $1,069 · 2023: $776 · 2024: $801 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,080.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $884.13 | 2021-2024 | Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $455.98 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $375.99 | 2021-2024 | Brilinta, Imfinzi, Farxiga |
| Amgen INC. | $270.43 | 2021-2025 | Repatha, Repatha |
| Abiomed | $263.20 | 2022-2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $226.14 | 2022-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $175.60 | 2021-2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.55 | 2021-2023 | Lifevest |
| Cvrx, INC. | $169.11 | 2024-2025 | Barostim Neo System |
| Pfizer INC. | $123.41 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $110.21 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.66 | 2021-2024 | Jardiance |
| Edwards Lifesciences Corporation | $74.32 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Alnylam Pharmaceuticals INC. | $56.79 | 2024-2025 | Onpattro |
| Impulse Dynamics (USA) INC. | $45.72 | 2024 | Optimizer |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $45.07 | 2024 | |
| Sanofi-Aventis U.S. LLC | $45.07 | 2022-2023 | |
| Scpharmaceuticals INC. | $42.62 | 2025 | |
| Boston Scientific Corporation | $40.29 | 2023 | Watchman Access System |
| Vital Connect, INC | $31.37 | 2024 | Vitalpatch Rtm |
| Philips North America LLC | $30.69 | 2024 | (Ck4) Mcot |
| Cleerly, INC. | $29.09 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Esperion Therapeutics, INC. | $16.42 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Ooten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.